ANIP in the 13F filings
Ani Pharmaceuticals Inc · CUSIP 00182C103
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 25
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 4 listed it in both
- Shares listed
- 2,504,264
- combined, among listed positions
- Reported value
- $207m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 8 buyers (opened or added shares) and 17 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -796,307.
Managers listing ANIP in Q2 2026
25 of 25 holders
Largest increases and reductions, by shares
Increases
- Winton Group Ltdnew position · 55,058 shares now+55,058
- ExodusPoint Capital Management LPnew position · 32,838 shares now+32,838
- Fidelity (FMR LLC)existing position · 36,848 shares now+18,071
- AQR Capital Management LLCexisting position · 29,500 shares now+10,658
- AllianceBernstein LPexisting position · 27,532 shares now+7,200
Reductions
- Freestone Grove Partners LPexisting position · 101,332 shares now-152,898
- Schonfeld Strategic Advisors LLCexisting position · 41,217 shares now-144,412
- Man Group PLCexisting position · 80,496 shares now-128,198
- Renaissance Technologies LLCexisting position · 63,700 shares now-122,402
- Millennium Management LLCexisting position · 507,207 shares now-84,806
New positions and exits
New (2)
Exited (1)
- Polen Capital Management LLCwas $493k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2014 | 1 | $941k | n.a. | n.a. |
| Q4 2014 | 3 | $3.9m | n.a. | n.a. |
| Q1 2015 | 1 | $769k | n.a. | n.a. |
| Q2 2015 | 1 | $434k | n.a. | n.a. |
| Q3 2015 | 1 | $3.1m | n.a. | n.a. |
| Q1 2020 | 1 | $670k | n.a. | n.a. |
| Q2 2020 | 1 | $299k | n.a. | n.a. |
| Q4 2021 | 1 | $252k | n.a. | n.a. |
| Q3 2023 | 1 | $232k | n.a. | n.a. |
| Q1 2024 | 1 | $319k | 1 | 0 |
| Q2 2024 | 1 | $1.2m | 1 | 0 |
| Q3 2024 | 1 | $9.3m | 1 | 1 |
| Q4 2024 | 1 | $259k | n.a. | n.a. |
| Q1 2025 | 2 | $11m | 1 | 1 |
| Q2 2025 | 2 | $16m | 2 | 0 |
| Q3 2025 | 6 | $71m | 4 | 1 |
| Q4 2025 | 5 | $35m | 15 | 16 |
| Q1 2026 | 5 | $52m | 15 | 15 |
| Q2 2026 | 3 | $17m | 8 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ANIP and LLY →ANIP and JNJ →ANIP and VRTX →Choose a stock to compare with ANIP →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ANIP, latest filings →Back to the 13F Explorer →